Why the study?
Heart rate recovery is a critical indicator of cardiovascular fitness linked to disorders, highlighting its potential for identifying high-risk individuals using wearable devices.
Does a machine learning approach using ECG signals from a wearable smart shirt accurately classify individuals into high-risk and low-risk heart rate recovery groups?
Does a machine learning approach using ECG signals from a wearable smart shirt accurately classify individuals into high-risk and low-risk heart rate recovery groups?
Continuous ECG monitoring via a smart shirt combined with machine learning can accurately identify individuals with slow heart rate recovery, offering a feasible tool for cardiovascular risk assessment.
Answers are grounded in this paper and cite their sources.
May aid wearable-based risk stratification; hypothesis-generating and requires prospective validation before clinical adoption.
Heart rate recovery (HRR) is a critical indicator of cardiovascular fitness and autonomic nervous system function, reflecting the balance between sympathetic and parasympathetic activity. Slower HRR is often linked to cardiovascular and metabolic disorders, highlighting its potential for identifying high-risk individuals. In this study, we developed a feature engineering approach integrated to wearable device data to classify individuals into high-risk (slower HRR) and low-risk (faster HRR) groups. Data were collected from 38 participants (aged 20 to 76 years, 55.26% women) during treadmill trial, with ECG signals recorded using a smart shirt. Participants with an HRR equal to 28 beats per minute or below were classified as high-risk. Using machine learning classifiers, our approach achieved an area under the curve (AUC) score of 86% with Support Vector Classifier (SVC), demonstrating the feasibility of continuous heart health monitoring via wearable devices. Interestingly, age did not emerge as a significant predictor of HRR in our analysis, possibly due to the impact of lifestyle changes during the lockdown policy of COVID-19 era. This method holds promise for improving cardiovascular health monitoring accessibility and could support physicians in risk assessment and clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Bishnoi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: